Dose–response plasma appearance of coffee chlorogenic and phenolic acids in adults
Article first published online: 4 SEP 2013
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Molecular Nutrition & Food Research
Volume 58, Issue 2, pages 301–309, February 2014
How to Cite
Renouf, M., Marmet, C., Giuffrida, F., Lepage, M., Barron, D., Beaumont, M., Williamson, G. and Dionisi, F. (2014), Dose–response plasma appearance of coffee chlorogenic and phenolic acids in adults. Mol. Nutr. Food Res., 58: 301–309. doi: 10.1002/mnfr.201300349
- Issue published online: 3 FEB 2014
- Article first published online: 4 SEP 2013
- Manuscript Accepted: 11 JUL 2013
- Manuscript Revised: 8 JUL 2013
- Manuscript Received: 13 MAY 2013
- Nestec SA
- Chlorogenic acids;
- Phenolic acids
Coffee contains phenolic compounds, mainly chlorogenic acids (CGAs). Even though coffee intake has been associated with some health benefits in epidemiological studies, the bioavailability of coffee phenolics is not fully understood.
Objective and study design
We performed a dose–response study measuring plasma bioavailability of phenolics after drinking three increasing, but still nutritionally relevant doses of instant pure soluble coffee. The study design was a one treatment (coffee) three-dose randomized cross-over design, with a washout period of 2 wks between visits.
CGAs, phenolic acids, and late-appearing metabolites all increased with increasing ingested dose. Hence, the sum of area under the curve was significantly higher for the medium to low dose, and high to medium dose, by 2.23- and 2.38-fold, respectively. CGAs were not well absorbed in their intact form, regardless of the dose. CGA and phenolic acids appeared rapidly in plasma, indicating an early absorption in the gastrointestinal tract. Late-appearing metabolites were the most abundant, regardless of the dose.
This study confirmed previous findings about coffee bioavailability but also showed that coffee phenolics appear in a positive dose–response manner in plasma when drank at nutritionally relevant doses.